Clinical Trial Update: A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of TQ05105 tablets for chronic graft-versus-host disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• TQ05105

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: RECRUITING